Year |
Citation |
Score |
2021 |
Hitt DM, Zwicker JD, Chao CK, Patel SA, Gerdes JM, Bridges RJ, Thompson CM. Inhibition of the Vesicular Glutamate Transporter (VGLUT) with Congo Red Analogs: New Binding Insights. Neurochemical Research. PMID 33398639 DOI: 10.1007/s11064-020-03182-0 |
0.421 |
|
2019 |
Thompson CM, Gerdes JM. Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures. Neurobiology of Disease. PMID 31022458 DOI: 10.1016/J.Nbd.2019.04.011 |
0.312 |
|
2017 |
Neumann KD, Thompson CM, Blecha JE, Gerdes JM, VanBrocklin HF. An Improved Radiosynthesis of O-(2-[(18) F]Fluoroethyl)-O-(p-nitrophenyl)methylphosphonate: A First-in-Class Cholinesterase PET Tracer. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 28406525 DOI: 10.1002/Jlcr.3511 |
0.321 |
|
2016 |
Chao CK, Ahmed SK, Gerdes JM, Thompson CM. The Novel Organophosphate Ligand O-(2-Fluoroethyl)-O-(p-nitrophenyl)methylphosphonate: Synthesis, Hydrolytic Stability and Analysis of the Inhibition and Reactivation of Cholinesterases. Chemical Research in Toxicology. PMID 27551891 DOI: 10.1021/Acs.Chemrestox.6B00160 |
0.328 |
|
2015 |
Alfonsino G, Santagati A, Basile L, Novellino E, Gaul C, Squires C, Braden M, Gerdes J, Silanes S, Guccione S, Parker K. 5HT1a Receptor Binding Affinities of a Series of Serotonin Transporter (SERT) Inhibitors and Related Thermodynamic Insights Journal of Advances in Medical and Pharmaceutical Sciences. 4: 1-12. DOI: 10.9734/Jamps/2015/18917 |
0.332 |
|
2014 |
James SL, Ahmed SK, Murphy S, Braden MR, Belabassi Y, VanBrocklin HF, Thompson CM, Gerdes JM. A novel fluorine-18 β-fluoroethoxy organophosphate positron emission tomography imaging tracer targeted to central nervous system acetylcholinesterase. Acs Chemical Neuroscience. 5: 519-24. PMID 24716794 DOI: 10.1021/Cn500024C |
0.318 |
|
2014 |
Carrigan CN, Patel SA, Cox HD, Bolstad ES, Gerdes JM, Smith WE, Bridges RJ, Thompson CM. The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids. Bioorganic & Medicinal Chemistry Letters. 24: 850-4. PMID 24424130 DOI: 10.1016/J.Bmcl.2013.12.086 |
0.493 |
|
2013 |
Kaleem Ahmed S, Belabassi Y, Sankaranarayanan L, Chao CK, Gerdes JM, Thompson CM. Synthesis and anti-acetylcholinesterase properties of novel β- and γ-substituted alkoxy organophosphonates. Bioorganic & Medicinal Chemistry Letters. 23: 2048-51. PMID 23453838 DOI: 10.1016/J.Bmcl.2013.02.010 |
0.342 |
|
2010 |
Huang Y, Zheng MQ, Gerdes JM. Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination? Current Topics in Medicinal Chemistry. 10: 1499-526. PMID 20583995 DOI: 10.2174/156802610793176792 |
0.315 |
|
2010 |
Guo L, Suarez AI, Braden MR, Gerdes JM, Thompson CM. Inhibition of acetylcholinesterase by chromophore-linked fluorophosphonates. Bioorganic & Medicinal Chemistry Letters. 20: 1194-7. PMID 20034789 DOI: 10.1016/J.Bmcl.2009.12.007 |
0.376 |
|
2010 |
Patel SA, Rajale T, O'Brien E, Burkhart DJ, Nelson JK, Twamley B, Blumenfeld A, Szabon-Watola MI, Gerdes JM, Bridges RJ, Natale NR. Isoxazole analogues bind the system xc- transporter: structure-activity relationship and pharmacophore model. Bioorganic & Medicinal Chemistry. 18: 202-13. PMID 19932968 DOI: 10.1016/J.Bmc.2009.11.001 |
0.467 |
|
2008 |
Hassani M, Cai W, Koelsch KH, Holley DC, Rose AS, Olang F, Lineswala JP, Holloway WG, Gerdes JM, Behforouz M, Beall HD. Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies. Journal of Medicinal Chemistry. 51: 3104-15. PMID 18457384 DOI: 10.1021/Jm701066A |
0.3 |
|
2007 |
Patel SA, Nagy JO, Bolstad ED, Gerdes JM, Thompson CM. Tetrapeptide inhibitors of the glutamate vesicular transporter (VGLUT). Bioorganic & Medicinal Chemistry Letters. 17: 5125-8. PMID 17662605 DOI: 10.1016/J.Bmcl.2007.07.006 |
0.43 |
|
2005 |
Hassani M, Cai W, Holley DC, Lineswala JP, Maharjan BR, Ebrahimian GR, Seradj H, Stocksdale MG, Mohammadi F, Marvin CC, Gerdes JM, Beall HD, Behforouz M. Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1. Journal of Medicinal Chemistry. 48: 7733-49. PMID 16302813 DOI: 10.1021/Jm050758Z |
0.325 |
|
2005 |
Esslinger CS, Agarwal S, Gerdes J, Wilson PA, Davis ES, Awes AN, O'Brien E, Mavencamp T, Koch HP, Poulsen DJ, Rhoderick JF, Chamberlin AR, Kavanaugh MP, Bridges RJ. The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3. Neuropharmacology. 49: 850-61. PMID 16183084 DOI: 10.1016/J.Neuropharm.2005.08.009 |
0.381 |
|
2005 |
Thompson CM, Davis E, Carrigan CN, Cox HD, Bridges RJ, Gerdes JM. Inhibitor of the glutamate vesicular transporter (VGLUT). Current Medicinal Chemistry. 12: 2041-56. PMID 16101493 DOI: 10.2174/0929867054637635 |
0.528 |
|
Show low-probability matches. |